Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Abraaj and Proparco sell part of their stake in Tunisian pharma company Unimed

Posted 7 years ago

Region:

Bosnia, Washington, Europe, Africa, United States of America, Turkey, Tunisia, San Marino, Slovakia, Sweden, Russia, Serbia, Romania, Portugal, Poland, Norway, Netherlands, Malta, Monaco, Luxembourg, Liechtenstein, Italy, Iceland, Ireland, Hungary, Croatia, Greece, United Kingdom, France, Finland, Spain, Egypt, Denmark, Germany, Czech Republic, Switzerland, Belgium, Austria, Andorra
Sector:

Pharmaceuticals, Biotechnology & Life Sciences, Consumer Services
Deal Size:
Buy Side Company:
SQM, Blakeney Asset Management, Tunisian-Kuwaiti Consortium of Development
Sell Side Company:
The Abraaj Group, Proparco SA
Target Company:

Global growth investor Abraaj Group and development finance institution Proparco, have sold part of their respective stakes in Unimed, a Tunisian pharmaceutical company to a group of buyers. The buyers include SQM, Blakeney Asset Management and the Tunisian-Kuwaiti Consortium of Development. Abraaj and Proparco exited 83% of their combined stake to the consortium of investors. Established in 1989, Unimed is the second largest local pharmaceutical company in Tunisia, specializing in sterile dosage forms such as liquid and powder injectables, intravenous (IV) solutions and a range of ophthalmic products. Financial details of the deal were not disclosed.

Why should I add a proposition?

Find counterparties that match your capital requirement or investment criteria
Get verified, vetted and analyst-picked introductions to relevant propositions
Generate new relationships
Add Proposition

Aurigin Updates

BB0065509 got introduced to BB0068597 18 hours ago
BB0018577 received an introduction for this Proposition yesterday
BB0068333 received an introduction for this Proposition yesterday
BB0068333 requested for a profile disclosure for this Proposition yesterday
BB0015199 received an introduction for this Proposition yesterday

Securities are offered through Finalis Securities LLC, member of FINRA / SIPC. Aurigin is not a registered broker-dealer, and Finalis Securities LLC and Aurigin are separate, unaffiliated entities.

www.aurigininc.com is a website operated by Aurigin Inc., a privately held Delaware corporation. Aurigin provides deal origination services. Other services, such as securities-related transactions, are offered separately by Sohil Poojara in their capacity as registered representatives of Finalis Securities LLC, member of FINRA/SIPC.